Showing results (191-200 of 232) with videos related to
Sort By:
Pageof 24
The Journal of Rheumatology|November 1, 1990
L-tryptophan associated eosinophilia-myalgia syndromeJ D Katz, C J Wakem, A L ParkeLeukemia|October 24, 2008
Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen speciesE Ortiz-Sánchez, T R Daniels, G Helguera, et al.The American Journal of Cardiology|July 15, 1997
Predictors of natural killer cell-mediated cytotoxicity deficiency in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathyL V Doering, D L Vredevoe, M A Woo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosisR Uslu, N Borsellino, P Frost, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Cytotoxic properties of a new synthetic demethylpodophyllotoxin derivative, BN 58705, against human tumor cell linesH Morimoto, P Principe, J P Robin, et al.European Journal of Immunology|November 1, 1976
Immune response of New Zealand mice to trinitrophenylated syngeneic mouse red cellsD Naor, B Bonavida, R A Robinson, et al.International Journal of Oncology|May 14, 2011
Sensitivity of drug-resistant B-cell lines from AIDS-related non-hodgkins-lymphoma to newly synthesized podophyllotoxin derivatives and aza-alkyllysophospholipids - enhanced sensitization by pretreatment with interferon-gammaA Demidem, C Broquet, J Menciahuerta, et al.Transplantation|May 26, 2001
CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched modelM P Fischbein, J Yun, H Laks, et al.Biochemical and Biophysical Research Communications|September 30, 1991
Class II antigen-associated invariant chain mRNA in mouse small intestineA J Ouellette, D Frederick, S J Hagen, et al.Cell|September 24, 1993
Following a diabetogenic T cell from genesis through pathogenesisJ D Katz, B Wang, K Haskins, et al.Pageof 24